radiotherapeutic drug for intractable cancer
Link for Life
LinqMed Inc., a certified venture company of the National Institutes for Quantum Sciences and Technology (QST),
is a start-up radiopharmaceutical company to provide innovative “visible” anti-cancer treatments to patients.
Linking Innovative Science and Medicine for Your Health and Happiness
Location and contact information of LinqMed Inc.
Development of Next-Generation Radiopharmaceuticals for Both Diagnosis and Treatment of Cancer, Utilizing the Copper Radioisotope 64Cu.
The latest information about LinqMed Inc.
LinqMed was featured in Yomiuri Shimbun Online
Announcement of selection for NEDO “The Deep-Tech Startup Support Fund/Deep-Tech Startup Support Program”
LinqMed Announces Series A and additional Financing
LinqMed and PeptiDream Announce Strategic Partnership for the Development and Commercialization of 64Cu-ATSM in Japan
Article published in the Japan Economic Research Institute “JERI Monthly Report”